Serum KLRB1 (CD161) as a discriminative biomarker in community-acquired pneumonia

Buğra Kerget; Ferhan Kerget; Hatice Beyza Özkan; Esra Laloğlu

doi:10.1080/17520363.2025.2600247

Abstract

Serum KLRB1 may serve as a valuable biomarker to differentiate between viral and bacterial CAP, supporting early diagnosis and optimized treatment decisions.

Affiliated Institutions

Related Publications

Using Artificial Intelligence to Detect COVID-19 and Community-acquired Pneumonia Based on Pulmonary CT: Evaluation of the Diagnostic Accuracy

Lin Li , Lixin Qin , Zeguo Xu +15 more

Background Coronavirus disease 2019 (COVID-19) has widely spread all over the world since the beginning of 2020. It is desirable to develop automatic and accurate detection of C...

2020 Radiology 1993 citations

Does this patient have community-acquired pneumonia? Diagnosing pneumonia by history and physical examination.

Joshua P. Metlay , Wishwa N. Kapoor , Michael Fine

Community-acquired pneumonia is an important cause of acute respiratory symptoms (eg, cough) in the ambulatory care setting. Distinguishing pneumonia from other causes of respir...

1997 PubMed 203 citations

The prognostic landscape of genes and infiltrating immune cells across human cancers

Andrew J. Gentles , Aaron M. Newman , Chih Long Liu +11 more

Molecular profiles of tumors and tumor-associated cells hold great promise as biomarkers of clinical outcomes. However, existing data sets are fragmented and difficult to analyz...

2015 Nature Medicine 3132 citations

Surface‐enhanced Raman sensors: early history and the development of sensors for quantitative biowarfare agent and glucose detection

Christy L. Haynes , Chanda Ranjit Yonzon , Xiaoyu Zhang +1 more

Abstract Surface‐enhanced Raman spectroscopy (SERS) is a powerful technique for the sensitive and selective detection of low‐concentration analytes. This paper includes a discus...

2005 Journal of Raman Spectroscopy 351 citations

Do Men Make Informed Decisions about Prostate Cancer Screening? Baseline Results from the “Take the Wheel” Trial

Jennifer D. Allen , Megan Othus , Alton Hart +3 more

Background. The efficacy of prostate cancer (CaP) screening with the prostate-specific antigen (PSA) test is debated. Most medical organizations recommend that men make individu...

2010 Medical Decision Making 22 citations

Publication Info

Year: 2025
Type: article
Pages: 1-8
Citations: 0
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Serum KLRB1 (CD161) as a discriminative biomarker in community-acquired pneumonia

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

OpenAlex

Cite This

APA Style

                            
                                    Buğra Kerget, 
                                
                                    Ferhan Kerget, 
                                
                                    Hatice Beyza Özkan
                                
                                et al.
                            
                            (2025). 
                            Serum KLRB1 (CD161) as a discriminative biomarker in community-acquired pneumonia. 
                            Biomarkers in Medicine
                            
                            , 1-8.
                            https://doi.org/10.1080/17520363.2025.2600247

Identifiers

DOI: 10.1080/17520363.2025.2600247